This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What's in the Cards for Tanger (SKT) This Earnings Season?
by Zacks Equity Research
Despite Tanger Factory Outlet Centers' (SKT) focus on improving tenant mix, amenities and marketing programs, its Q4 results might be affected by store closures, bankruptcies and lease modifications.
Key Factors to Impact JLL's Performance This Earnings Season
by Zacks Equity Research
Jones Lang LaSalle's (JLL) Q4 results likely to reflect strength across its global regions and rising trend of outsourcing of real estate needs by companies.
CBRE Group (CBRE) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
CBRE Group (CBRE) will likely gain from improving occupier outsourcing business and strategic buyouts. Nonetheless, investors' cautious approach, trade tensions and political uncertainty remain woes.
Moving Average Crossover Alert: Sabra Healthcare
by Zacks Equity Research
Sabra Healthcare REIT, Inc. (SBRA) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Sabra Healthcare (SBRA) Misses Q3 FFO and Revenue Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of -11.29% and -6.66%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Alexandria Acquires 219 East 42nd Street, Boosts Portfolio
by Zacks Equity Research
Expanding its regional life-science cluster franchise in New York City, Alexandria Real Estate Equities (ARE) acquires a Manhattan office property through membership interest in 219/235 East LLC.
Sabra Health Care Disposes Genesis & Signature Facilities
by Zacks Equity Research
Sabra Health Care (SBRA) to use proceeds from sale of nine Genesis Healthcare facilities, and another project leased to Signature Healthcare to reduce balance under its revolving credit facility.
Aimco (AIV) to Report Q1 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Aimco's (AIV) Q1 results are likely to gain from elevated demand as a result of favorable demographics. Further, the company's diligent efforts to reposition its portfolio will help it perform better.
Host Hotels (HST) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Host Hotels & Resorts (HST) Q1 results likely to reflect benefits from its portfolio of upscale hotels across potential markets and productivity gains, and impact of high supply and tough comparisons.
Sabra Health Care (SBRA) Disposes 20 Genesis Facilities
by Zacks Equity Research
Sabra Health Care REIT's (SBRA) sale of 20 skilled nursing facilities highlights its ability to prudently divest troubled facilities and focus on better quality assets.
What's in the Offing for HCP Inc (HCP) This Earnings Season?
by Zacks Equity Research
HCP Inc's (HCP) Q3 results are likely to gain from rising healthcare spending and strategic investments. Yet, increased supply of senior housing assets and dilutive impact of assets sale remain concerns.
Host Hotels (HST) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Host Hotels & Resorts' (HST) third-quarter results anticipated to bear the impact of the holiday shift as well as tough comps due to the Olympics held in Brazil last year.
Extra Space Storage (EXR) Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Extra Space Storage (EXR) is likely to experience solid demand backed by favorable demographic changes. High brand value, strategic buyouts and robust presence in key cities serve as growth drivers.
Duke Realty (DRE) Refinances Loan to Upsize Credit Facility
by Zacks Equity Research
Duke Realty's (DRE) amended credit facility will likely help the company expand its industrial portfolio.
Kilroy Realty Preleases 736,000 SF Office Space to Dropbox
by Zacks Equity Research
Kilroy Realty's (KRC) prelease of office space at The Exchange, before its completion, makes it the largest individual commercial negotiation of San Francisco.
Duke Realty (DRE) Announces Leasing Activities in TRIP 13111
by Zacks Equity Research
Duke Realty's (DRE) Tampa Regional Industrial Park 13111 ropes in two new tenants for 274,085 square feet of space.
Liberty Property's (LPT) Tenant Signs Long-Term Lease Deal
by Zacks Equity Research
Liberty Property Trust's (LPT) 5651 Innovation Boulevard to achieve full occupancy, as COKeM signs a long term lease for industrial space in the property.
Aging Americans to Aid Healthcare REITs: 3 Stocks to Buy Now
by Zacks Equity Research
Favorable demography amid the aging baby-boomer generation and greater longevity encourages healthcare REITs to tap opportunities and become resilient.
Don't Sell SL Green Realty (SLG) Stock Now -- Here's Why
by Zacks Equity Research
While a challenging retail and office real estate market might curb SL Green Realty's (SLG) bottom-line growth, prudent investment decisions and efficient capital management will help the company incubate its business.
SL Green Realty (SLG) Prices Senior Notes Worth $500M
by Zacks Equity Research
SL Green Realty (SLG) raises funds to repay senior notes maturing in 2017.
Vornado Realty's Q3 Results to Reflect Non-Recurring Loss
by Zacks Equity Research
Vornado Realty (VNO) to record certain non-recurring expenses, which are likely to weigh on its Q3 earnings.
Healthcare Realty (HR) Calls to Redeem Senior Notes Due 2021
by Zacks Equity Research
Healthcare Realty Trust (HR) to pay $113.4 million for early redemption of $100 million of the $400 million senior notes due in 2021.
Lexington Realty (LXP) Buys Industrial Portfolio for $200M
by Zacks Equity Research
Lexington Realty Trust's (LXP) recent acquisition of industrial portfolio is anticipated to expand the company's portfolio in upscale industrial markets.
Why Should You Add Prologis (PLD) to Your Portfolio Now?
by Zacks Equity Research
Prologis (PLD) continues to depict robust fundamentals and improving prospects. Further, this Zacks Rank #2 (Buy) stock has risen 20.2% year to date.
Sabra Inks Deal to Buy Stake in Enlivant Joint Ventures
by Zacks Equity Research
The joint ventures stake acquisition will raise Sabra Health Care REIT's (SBRA) percentage of cash NOI from private payors. Also, it would diversify the Sabra portfolio by tenant.